Author

Ofra Levy-Hacham

Observed name: O Levy-Hacham

Institution: Sol-Gel Technologies (Israel)

Observed institutions: University of California, San Francisco, Sol-Gel Technologies (Israel)

OpenAlex ID: A5021169517

Efficacy and safety of microencapsulated benzoyl peroxide and microencapsulated tretinoin for the treatment of acne vulgaris: Results from two phase 3 double-blind, randomized, vehicle-controlled studies

2023 · James Del Rosso, Jeffrey Sugarman, et al. · Journal of the American Academy of Dermatology · 27

PDF

Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Rosacea: Results From Two Phase III, Randomized, Vehicle-Controlled Trials.

2023 · Neal D Bhatia, Wm Philip Werschler, et al. · PubMed Central · 11

PDF

Sixty Years of Benzoyl Peroxide Use in Dermatology

2022 · Hilary Baldwin, Boni Elewski, et al. · Journal of Drugs in Dermatology · 11

Impact of Topical Vehicles and Cutaneous Delivery Technologies on Patient Adherence and Treatment Outcomes in Acne and Rosacea.

2023 · Linda Stein Gold, Pearl Kwong, et al. · PubMed Central · 8

PDF

Microencapsulated Benzoyl Peroxide and Tretinoin for the Treatment of Acne Vulgaris: Results from a Phase 2 Multicenter, Double-Blind, Randomized, Vehicle-Controlled Study.

2020 · Guy F Webster, Jeffrey Sugarman, et al. · PubMed · 8

Long-term Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Rosacea: Results From an Extension of Two Phase III, Vehicle-controlled Trials.

2023 · William P Werschler, Jeffrey Sugarman, et al. · PubMed Central · 7

PDF

Effect of Topical Microencapsulated Benzoyl Peroxide on the Skin Microbiome in Rosacea: A Randomized, Double-Blind, Crossover, Vehicle-Controlled Clinical Trial.

2024 · Yvonne Nong, Jeffrey Sugarman, et al. · PubMed Central · 4

PDF

Real-World Adverse Events Associated with Encapsulated Benzoyl Peroxide/Tretinoin, 3%/0.1%, and Encapsulated Benzoyl Peroxide, 5%

2024 · Amy Poteate, Ofra Levy-Hacham, et al. · Dermatology and Therapy · 2

PDF

Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Papulopustular Rosacea in Elderly Patients: Post-hoc Analysis of Results from Two Randomized, Phase III, Vehicle-controlled Trials.

2024 · Lawrence J Green, Hilary Baldwin, et al. · PubMed Central · 1

PDF

Efficacy and Safety of Microencapsulated Benzoyl Peroxide 3% and Microencapsulated Tretinoin 0.1% (E-Bpo/E-Atra) in Acne Vulgaris: Results from Two Randomized Controlled Clinical Trials

2021 · J Del Rosso, O Levy-Hacham, et al. · SKIN The Journal of Cutaneous Medicine · 1

PDF

Impact of Microencapsulated Benzoyl Peroxide on the Skin Microbiome and Clinical Outcomes in Rosacea: An Update on a Randomized, Double-blind, Crossover, Vehicle-controlled Clinical Trial.

2025 · Yvonne Nong, Jeffrey Sugarman, et al. · PubMed Central

48854 Treatment with encapsulated benzoyl peroxide leads to a durable shift in the microbiome in rosacea

2024 · Raja K. Sivamani, Yvonne Nong, et al. · Journal of the American Academy of Dermatology

PDF

41694 Evolution of Benzoyl Peroxide: Microencapsulated 5% Cream to Improve Tolerability in Papulopustular Rosacea

2023 · Hilary Baldwin, Boni Elewski, et al. · Journal of the American Academy of Dermatology

PDF

42739 Microencapsulated Benzoyl Peroxide, 5%, Is Well Accepted by Patients With Rosacea: Patient- Reported Outcomes and Results From Two Phase 3, Randomized, Vehicle-Controlled Trials

2023 · Neal D. Bhatia, Wm. Philip Werschler, et al. · Journal of the American Academy of Dermatology

PDF

43621 An Evaluation of the Phototoxic and Photoallergic Potential of Microencapsulated Benzoyl Peroxide and Tretinoin

2023 · Jeffrey Sugarman, Rinat Mizrahi, et al. · Journal of the American Academy of Dermatology

PDF

Works count: 15

Citation count: 80

H-index: 6

I10-index: 3